FUS and amyotrophic lateral sclerosis: Further reinforcing the concept that prevention of FUS nuclear translocation has antifibrotic potential, patients affected by amyotrophic lateral sclerosis carrying mutations of FUS known to confer cytoplasmic gain of function have a decreased amount of collagen IV in skin, urine, and plasma (13–15).